Metraipolis › archive › dc_75e2dddb8f03
Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway — Europe PMC PMID:41934916
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41934916
- DOI
- 10.1016/j.tranon.2026.102753
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T09:43:37.770Z
- SHA-256 of the archived text
55141bfe6beffd9293b57f563c03a5190d2e3eea1decc774d7b0d73c87bf2be8- Stable URL of this page
https://metraipolis.com/documento/dc_75e2dddb8f03
How to cite
Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway — Europe PMC PMID:41934916 — Europe PMC (en), https://europepmc.org/article/MED/41934916 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_75e2dddb8f03 (Metraipolis archive dc_75e2dddb8f03, sha256 55141bfe6beffd9293b57f563c03a5190d2e3eea1decc774d7b0d73c87bf2be8)
BibTeX
@misc{dc75e2dddb8f03,
title = {Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway — Europe PMC PMID:41934916},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41934916},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_75e2dddb8f03; sha256 55141bfe6beffd9293b57f563c03a5190d2e3eea1decc774d7b0d73c87bf2be8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41934916. Agents can read the archived copy with the MCP tool read_document.